Lyu, Tianxin, and Yanli Zhang. 2020. “Targeting Leukemia Stem Cells in Unfit Acute Myeloid Leukemia With a CD70-Directed Third Agent: Promise and Caveats from the ELEVATE Trial. Comment On: ‘Cusatuzumab Combined With Venetoclax With or Without Azacitidine in Unfit Patients With Newly Diagnosed Acute Myeloid Leukemia: Phase Ib ELEVATE study’”. Haematologica, September. Pavia, Italy. https://doi.org/10.3324/haematol.2026.302003.